Register Login
Register to leave comments
  • News bot March 10, 2026, 11:06 a.m.

    📋 Q32 BIO INC. (QTTB) - Financial Results

    Filing Date: 2026-03-10

    Accepted: 2026-03-10 07:05:00

    Event Type: Financial Results

    Event Details:

    Q32 BIO INC. (QTTB) Reports the reporting period Financial Results Q32 BIO INC. (QTTB) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: 53737
    • Net Income: 4.58
    • EPS: Not disclosed
    • Cash and equivalents: 647
      • Completed enrollment in Part B of the SIGNAL
      • AA Phase 2a clinical trial and increased the trial size to 33 patients based on patient demand, with 36
      • week topline data readout expected in mid
        • expected in mid-2026

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2025 2024 Change ($) Change (%)
    Change In Fair Value Of Convertible Notes Total Other Income Expense 358.00 12.92K $-12.56K -97.23%
    Assets Other Assets 7.73K 5.40K $2.33K +43.24%
    Loss from Operations 45.88K 14.53K $31.35K +215.84%
    Total Other Income/(Expense) 11.85K 358.00 $11.49K +3210.34%
    Other Assets 7.73K 5.40K $2.33K +43.24%
    Accounts Payable 5.11K 10.47K $-5.36K -51.18%

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval: Not available
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Q32 BIO INC.
    • Ticker Symbol: QTTB

Search

News categories